MRI has several advantages relative to other imaging modalities in evaluating, diagnosing, and planning treatment for prostate cancer. However, it is rarely ordered for localized disease. While the ...
Polo-like kinase-1 as a potential prognostic marker of prostate cancer utilizing ORIEN data. This is an ASCO Meeting Abstract from the 2023 ASCO Genitourinary Cancers Symposium. This abstract does not ...
The phase 3 MAGNOLIA trial will assess whether abelacimab can prevent venous thromboembolism recurrence in patients with gastrointestinal or genitourinary cancers. Recruitment has started for a phase ...
FORT MYERS, Fla., Jan. 30, 2025 /PRNewswire/ -- Clinical research conducted at Florida Cancer Specialists & Research Institute, LLC (FCS) is expanding treatment options and contributing to improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback